Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Estevam GO"'
Autor:
Estevam GO; Tetrad Graduate Program, University of California, San Francisco, San Francisco, United States.; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, United States., Linossi EM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States., Macdonald CB; Tetrad Graduate Program, University of California, San Francisco, San Francisco, United States., Espinoza CA; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States., Michaud JM; Tetrad Graduate Program, University of California, San Francisco, San Francisco, United States., Coyote-Maestas W; Tetrad Graduate Program, University of California, San Francisco, San Francisco, United States.; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, United States., Collisson EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States.; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, United States., Jura N; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, United States., Fraser JS; Tetrad Graduate Program, University of California, San Francisco, San Francisco, United States.; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, United States.
Publikováno v:
ELife [Elife] 2024 Sep 13; Vol. 12. Date of Electronic Publication: 2024 Sep 13.
Autor:
Estevam GO; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States.; Tetrad Graduate Program, UCSF, San Francisco, CA, United States., Linossi EM; Cardiovascular Research Institute, UCSF, San Francisco, CA, United States.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, United States., Rao J; Department of Computer Science, UCLA, Los Angeles, CA, United States., Macdonald CB; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States., Ravikumar A; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States., Chrispens KM; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States.; Biophysics Graduate Program, UCSF, San Francisco, CA, United States., Capra JA; Bakar Computational Health Sciences Institute and Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, United States., Coyote-Maestas W; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States.; Quantitative Biosciences Institute, UCSF, San Francisco, CA, United States., Pimentel H; Department of Computer Science, UCLA, Los Angeles, CA, United States.; Department of Computational Medicine and Human Genetics, UCLA, Los Angeles, CA, United States.; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States., Collisson EA; Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, United States.; Department of Medicine, University of Washington, Seattle, Washington, United States., Jura N; Cardiovascular Research Institute, UCSF, San Francisco, CA, United States.; Department of Cellular and Molecular Pharmacology, UCSF, San Francisco, CA, United States.; Quantitative Biosciences Institute, UCSF, San Francisco, CA, United States., Fraser JS; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, United States.; Quantitative Biosciences Institute, UCSF, San Francisco, CA, United States.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 18. Date of Electronic Publication: 2024 Jul 18.
Autor:
Rao J; Department of Computer Science, UCLA, Los Angeles, CA, USA., Xin R; Computational and Systems Biology Interdepartmental Program, UCLA, Los Angeles, CA, USA., Macdonald C; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA., Howard MK; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA.; Tetrad Graduate Program, UCSF, San Francisco, CA, USA.; Department of Pharmaceutical Chemistry, UCSF, San Francisco, CA, USA., Estevam GO; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA.; Tetrad Graduate Program, UCSF, San Francisco, CA, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA., Wang M; Department of Mathematics, Baruch College, CUNY, New York, NY, USA., Fraser JS; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA.; Quantitative Biosciences Institute, UCSF, San Francisco, CA, USA., Coyote-Maestas W; Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA, USA. willow.coyote-maestas@ucsf.edu.; Quantitative Biosciences Institute, UCSF, San Francisco, CA, USA. willow.coyote-maestas@ucsf.edu., Pimentel H; Department of Computer Science, UCLA, Los Angeles, CA, USA. hjp@ucla.edu.; Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. hjp@ucla.edu.; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. hjp@ucla.edu.
Publikováno v:
Genome biology [Genome Biol] 2024 May 24; Vol. 25 (1), pp. 138. Date of Electronic Publication: 2024 May 24.
Autor:
Estevam GO; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States.; Tetrad Graduate Program, University of California San Francisco, San Francisco, United States., Linossi EM; Cardiovascular Research Institute, University of California San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, United States., Macdonald CB; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States., Espinoza CA; Tetrad Graduate Program, University of California San Francisco, San Francisco, United States.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, United States., Michaud JM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States., Coyote-Maestas W; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States.; Quantitative Biosciences Institute, University of California, San Francisco, United States, United States., Collisson EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, United States.; Department of Medicine/Hematology and Oncology, University of California, San Francisco, United States., Jura N; Cardiovascular Research Institute, University of California San Francisco, San Francisco, United States.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, United States.; Quantitative Biosciences Institute, University of California, San Francisco, United States, United States., Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States.; Quantitative Biosciences Institute, University of California, San Francisco, United States, United States.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 May 06. Date of Electronic Publication: 2024 May 06.
Autor:
Guérin C, Vinchent A, Fernandes M, Damour I, Laratte A, Tellier R, Estevam GO, Meneboo JP, Villenet C, Descarpentries C, Fraser JS, Figeac M, Cortot AB, Rouleau E, Tulasne D
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 07. Date of Electronic Publication: 2023 Nov 07.
Autor:
Linossi EM; Cardiovascular Research Institute, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Estevam GO; Department of Bioengineering and Therapeutic Sciences, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Oshima M; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA 94158, U.S.A.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Collisson EA; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA 94158, U.S.A.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California - San Francisco, San Francisco, CA 94158, U.S.A., Jura N; Cardiovascular Research Institute, University of California - San Francisco, San Francisco, CA 94158, U.S.A.; Department of Cellular and Molecular Pharmacology, University of California - San Francisco, San Francisco, CA 94158, U.S.A.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2021 Apr 30; Vol. 49 (2), pp. 645-661.